The Obesity Picture in Türkiye
According to the World Obesity Federation (World Obesity Atlas 2026) and TÜİK data, Türkiye is positioned among the high-prevalence countries in the European Region in terms of adult obesity prevalence. In line with data from the Turkish Statistical Institute (TÜİK) Health Survey, adult obesity prevalence is reported at approximately 25% in men and approximately 41% in women (Source: TÜİK Türkiye Health Survey; World Obesity Atlas 2026).
According to the global obesity analysis published by the World Health Organization (WHO) and in The Lancet, more than 1 billion people worldwide are living with obesity; this burden has increased roughly fourfold since 1990 (Source: WHO Obesity Fact Sheet 2024; NCD Risk Factor Collaboration, Lancet 2024).
Why Does It Matter?
Obesity is not merely an appearance problem; it is a chronic health condition strongly associated with type 2 diabetes, cardiovascular disease, joint problems, and certain types of cancer.
- Epidemiological cohort studies have consistently shown that obesity markedly increases the risk of developing type 2 diabetes; in severe obesity the increase in risk can reach manifold levels (the magnitude of the risk varies with body mass index, age, and accompanying factors). (Source: WHO/IDF metabolic risk assessments)
- Obesity-related health expenditures continue to rise every year
- In Türkiye, the working population aged 18–45 makes up one of the rapidly growing groups
Current Treatment Options
The evidence-based approaches in weight management are:
| Method | Eligibility | Notes |
|---|---|---|
| Lifestyle modification | All BMI groups | Fundamental, indispensable |
| Swallowable gastric balloon | BMI ≥ 27 | No surgery, 16 weeks |
| GLP-1 receptor agonists | BMI ≥ 30 + comorbidity | Long-term use under physician supervision; weight regain after discontinuation of treatment has been reported (PMID 41399474) |
| Bariatric surgery | BMI ≥ 40 or ≥ 35 + comorbidity | Invasive surgical method; high and long-lasting weight-loss efficacy has been reported in suitable patients |
Allurion in Türkiye
The Allurion procedure-free (no anesthesia and no endoscopy) swallowable gastric balloon is offered in more than 60 authorized clinics across Türkiye. With data obtained from more than 200,000 placements worldwide, its safety and tolerability profile is continuously monitored and documented (Source: Data on File, Allurion 2026; see also PMID 41037243 for multicenter safety data).
This information is for general educational purposes. Always consult your specialist physician for personal health decisions.
To see authorized clinics in Türkiye →
Related Topics
- Obesity in Türkiye: 2026 Report →
- Who Is the Allurion Gastric Balloon For? →
- Weight Loss with a Gastric Balloon →
Authorized Clinics Near You
You can have the Allurion Program at more than 60 authorized clinics across Türkiye. For clinics in major cities:
Related Articles
Which Weight-Loss Method Is Right for Whom? An Evidence-Based 2026 Comparison Guide
Which weight-loss method is most effective in 2026? Lifestyle, gastric balloon, GLP-1 medications, and bariatric surgery: an evidence-based comparison and a guide to choosing what's right for you.
The Link Between Obesity and Type 2 Diabetes — The Gastric Balloon Effect
The relationship between obesity and type 2 diabetes, the effect of weight loss on HbA1c, and up-to-date information on the use of the Allurion Program in diabetic patients.
30 Questions About the Gastric Balloon: Comprehensive Answers and FAQ
The 30 most frequently asked questions about the gastric balloon, with answers based on clinical data. Everything about the procedure, safety, nutrition, pricing, and results.
Related Pages
Which method is right for you?
Let our specialist physicians evaluate you free of charge.
Free Pre-Assessment →